On February 8th, Italian electronic cigarette vertical media, sigmagazine, received a response letter from Set Spa, the exclusive distributor of ELFBAR in Italy. The letter stated that issues with ELFBAR were only limited to the UK and that all products in Italy are compliant with regulations.
The contents of the letter are as follows:
Dear Director,
We have come across an article published by you on your online publication on February 7th. The article is titled "Elf Bar 600 Disposable E-cigarette temporarily banned from UK market.
As a distributor of problematic products in the Italian market, Set Spa, we would like to point out that, to our knowledge, the issues in the UK market only concern certain batches of the products and do not exist in any way in the devices being released into our market.
Before releasing it to the market, we conducted strict inspections. Yesterday, February 7th, we conducted identical inspections at the independent Accredia certification laboratory for each batch and flavor to verify that the liquid levels met the effective legislation. Therefore, it seems our responsibility to inform consumers and industry operators concerned about your Elfbar products, all of which comply with the Law 6/2016.
We regret to inform you that our competitors have engaged in defamatory business practices aimed at tarnishing our brand over the past few hours. As this situation continues, we will take the necessary steps to protect our interests in the appropriate forum.
Reference:
ElfBar case, the distributor speaks: "Problem limited to Great Britain, in Italy everything is safe.
Further reading:
The ELFBAR product has been removed from British supermarkets for containing 50% more nicotine than allowed by regulations.
Wholesalers urgently recall ELFBAR products that exceed safety standards; 2 supermarkets have added the products to their list of items to remove from their shelves.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
